7/22/2020 7:22:53 AM
Myriad Genetics Adds Daniel Skovronsky To Board; Walter Gilbert To Retire From Board
7/7/2020 7:24:15 AM
Myriad Announces New Studies Validating Ability Of RiskScore Test
7/6/2020 7:10:16 AM
Myriad Announces New Collaboration With OptraHEALTH To Implement Cognitive ChatBOT Named Gene
7/1/2020 7:12:53 AM
Myriad Genetics Launches New Patient Home Collection Kit For GeneSight® Psychotropic Test
6/15/2020 7:12:27 AM
Myriad Genetics Receives Favorable Coverage Decisions For Prolaris
6/4/2020 7:08:25 AM
Myriad Genetics Reports Publication Of Prospective Clinical Study Of EndoPredict Test
5/28/2020 7:19:33 AM
Myriad Genetics Names Daniel Spiegelman To Its Board
5/20/2020 7:08:07 AM
Myriad Genetics Says FDA Approved BRACAnalysis CDx Test
5/11/2020 7:09:30 AM
Myriad Gets FDA Approval Of MyChoice CDx As Companion Diagnostic For Lynparza
5/5/2020 4:11:23 PM
Myriad Genetics Q3 Loss/Shr $1.55 Vs EPS $0.09 Last Year
4/8/2020 7:12:34 AM
Myriad Genetics Withdraws 2020 View Due To Business Impact From COVID-19
4/6/2020 7:12:37 AM
Myriad Genetics Receives Reimbursement And Launche BRACAnalysis In Japan